Literature DB >> 23902329

Longitudinal measurements of exhaled nitric oxide in children-what is a significant change in FE(NO) ?

Rebecca Cutts1, Steve Turner.   

Abstract

BACKGROUND: The principle aim of this study was to describe the variability of exhaled nitric oxide (FE(NO)) concentrations over 10 months in children with and without asthma.
METHODS: FE(NO) was measured on six occasions at 2-month intervals in a community-based cohort of children with and without asthma.
RESULTS: There were 178 children recruited, 47 had asthma, mean age 9.6 yr. A total of 851 FE(NO) measurements were made. The change in FE(NO) values was positively associated with the initial FE(NO) concentration (p < 0.001) and duration between paired measurements (p = 0.016) but not asthma diagnosis; there was an interaction between initial FE(NO) and duration between measurements. As an approximate rule-of-thumb, a child's FE(NO) may rise by up to 100% of their current FE(NO) over 2 and 4 months, independent of asthma.
CONCLUSIONS: Both the baseline FE(NO) and interval between repeated FE(NO) measurements are relevant to FE(NO) values, independent of asthma. These findings may be useful to clinical interpretation of FE(NO) results in children.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  asthma; child; longitudinal study; nitric oxide

Mesh:

Substances:

Year:  2013        PMID: 23902329     DOI: 10.1111/pai.12101

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  2 in total

1.  Fractional exhaled nitric oxide change in pediatric patients after emergency department care of asthma exacerbations.

Authors:  Eric Karlin; Tebeb Gebretsadik; R Stokes Peebles; Tina V Hartert; Emily W Langley; Donald H Arnold
Journal:  Ann Allergy Asthma Immunol       Date:  2014-12-06       Impact factor: 6.347

2.  Reducing Asthma Attacks in Children using Exhaled Nitric Oxide as a biomarker to inform treatment strategy: a randomised trial (RAACENO).

Authors:  S Turner; S C Cotton; C D Emele; R Thomas; S Fielding; E A Gaillard; J C de Jongste; H Morgan; A R Neilson; J Norrie; M Pijnenburg; D Price; M Thomas
Journal:  Trials       Date:  2019-10-04       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.